Literature DB >> 17629758

Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.

D Shitrit1, R Priess, N Peled, G Bishara, D Shlomi, M R Kramer.   

Abstract

This retrospective study sought to systematically identify clinical and radiological features differentiating Mycobacterium kansasii from Mycobacterium tuberculosis infection. The sample included matched patients with a culture-positive diagnosis of M. tuberculosis infection (n = 121) or M. kansasii infection (n = 62) derived from the databases of two tuberculosis centers. Data on patient background and clinical features were collected, and chest radiographs were analyzed. Sixty percent of the M. kansasii group were native Israelis compared to 15% of the M. tuberculosis group (p = 0.0001). M. tuberculosis infection was associated with a higher rate of human immunodeficiency virus (HIV) infection (p = 0.03) and M. kansasii infection with a higher rate of lung disease (p = 0.0001). M. tuberculosis infection was characterized by a higher likelihood of bilateral disease (p = 0.005), pleural effusions, and lymphadenopathy (p = 0.006 and p = 0.001, respectively). There were ten deaths, all in the M. tuberculosis group. On multivariate logistic regression, the presence of chronic obstructive pulmonary disease and associated lung disease were significant predictors of M. kansasii infection. The findings show that there are group differences between the clinical features of the two infections. In the setting of pulmonary mycobacterial infection, the presence of coinfection with HIV, bilateral disease, pleural effusion, and lymphadenopathy make M. kansasii infection very unlikely.

Entities:  

Mesh:

Year:  2007        PMID: 17629758     DOI: 10.1007/s10096-007-0331-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.

Authors:  M Lillo; S Orengo; P Cernoch; R L Harris
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Tuberculosis case finding among homeless men in New York City.

Authors:  A D CHAVES; A B ROBINS; H ABELES
Journal:  Am Rev Respir Dis       Date:  1961-12

Review 3.  The changing epidemiology of tuberculosis and other mycobacterial infections in the United States: implications for the radiologist.

Authors:  C B Buckner; R E Leithiser; C W Walker; J W Allison
Journal:  AJR Am J Roentgenol       Date:  1991-02       Impact factor: 3.959

4.  Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.

Authors:  E L Corbett; L Blumberg; G J Churchyard; N Moloi; K Mallory; T Clayton; B G Williams; R E Chaisson; R J Hayes; K M De Cock
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

Review 5.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

6.  Isolation of nontuberculous mycobacteria in the United States, 1980.

Authors:  R C Good; D E Snider
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

7.  Mycobacterium kansasii infections in patients with cancer.

Authors:  K L Jacobson; R Teira; H I Libshitz; I Raad; K V Rolston; J Tarrand; E Whimbey
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

8.  Expanding spectrum of pulmonary disease caused by nontuberculous mycobacteria.

Authors:  S M Albelda; J A Kern; D L Marinelli; W T Miller
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

9.  Pulmonary cavitations in Mycobacterium kansasii: distinctions from M. tuberculosis.

Authors:  J R Zvetina; T C Demos; N Maliwan; M Van Drunen; W Frederick; J Lentino; A M Modh
Journal:  AJR Am J Roentgenol       Date:  1984-07       Impact factor: 3.959

10.  Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.

Authors:  K C Bloch; L Zwerling; M J Pletcher; J A Hahn; J L Gerberding; S M Ostroff; D J Vugia; A L Reingold
Journal:  Ann Intern Med       Date:  1998-11-01       Impact factor: 25.391

View more
  7 in total

1.  Mycobacterium kansasii pulmonary infection: CT findings in 29 cases.

Authors:  Masashi Takahashi; Hiroaki Tsukamoto; Tetsuji Kawamura; Yoshirou Mochizuki; Masatsugu Ouchi; Shuhei Inoue; Norihisa Nitta; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2012-02-24       Impact factor: 2.374

2.  Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis.

Authors:  H Grubek-Jaworska; R Walkiewicz; A Safianowska; M Nowacka-Mazurek; R Krenke; T Przybyłowski; R Chazan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

3.  Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea.

Authors:  Hye Kyeong Park; Won-Jung Koh; Tae Sun Shim; O Jung Kwon
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

4.  Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

Authors:  C Maoz; D Shitrit; Z Samra; N Peled; L Kaufman; M R Kramer; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

5.  Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.

Authors:  Chang-Chieh Chen; Sheng-Hui Tsai; Chia-Chen Lu; Shiau-Ting Hu; Ting-Shu Wu; Tsung-Teng Huang; Najwane Saïd-Sadier; David M Ojcius; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

6.  Mycobacterium kansasii Pneumonia with Mediastinal Lymphadenitis in a Patient with Acute Myeloid Leukemia: Successful Treatment to Stem Cell Transplantation.

Authors:  Yeon Geun Choi; Sung Yeon Cho; Dong Gun Lee; Eunjung Yim; Hyonsoo Joo; Seongyul Ryu; Jae Ki Choi; Hee Je Kim
Journal:  Infect Chemother       Date:  2017-01-19

7.  Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review.

Authors:  Yingying Shen; Yuzhu Li; Hangchao Li; Qi Liu; Huijie Dong; Bo Wang; Baodong Ye; Shenyun Lin; Yiping Shen; Dijiong Wu
Journal:  Infect Drug Resist       Date:  2021-04-06       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.